DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Why Did Biotech Fall Off a Cliff in January?

Biotech's decline doesn't signal the start of a bear market for the industry. Here's why.

Notable Wednesday Option Activity: SRPT, MFLX, PSX

Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?

3 Feverishly Bad Flu Myths That Should Be Put to Rest

The flu might be the most misunderstood disease on the planet, and we're putting three of the most common myths to rest today.

3 Key FDA Decisions Expected in February

Structural Volatility Won't End For Several Years, Derivatives Strategist Says

3 Ways to Lose All Your Money in the Stock Market

Beware of these regrettable and potentially costly stock-market moves.

Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics

Biotech Stock Mailbag: Snow Stops Sarepta's FDA Show, so What's Next?

The FDA Just Crushed Sarepta Therapeutics' Hopes Of Releasing A Muscular Dystrophy Drug

See More Articles...